186 related articles for article (PubMed ID: 18699760)
21. The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens.
Fossella FV; Rigas J
Semin Oncol; 1999 Jun; 26(3 Suppl 11):9-12. PubMed ID: 10458204
[TBL] [Abstract][Full Text] [Related]
22. Single agents in the second-line treatment of non-small cell lung cancer.
Belani CP
Semin Oncol; 1998 Jun; 25(3 Suppl 8):10-4. PubMed ID: 9704670
[TBL] [Abstract][Full Text] [Related]
23. A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.
Ross HJ; Hart LL; Swanson PM; Rarick MU; Figlin RA; Jacobs AD; McCune DE; Rosenberg AH; Baron AD; Grove LE; Thorn MD; Miller DM; Drachman JG; Rudin CM
Lung Cancer; 2006 Oct; 54(1):69-77. PubMed ID: 16934909
[TBL] [Abstract][Full Text] [Related]
24. Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Feliu J; Martín G; Castro J; Sundlov A; Rodriguez-Jaráiz A; Casado E; Lomas M; Madroñal C; Galán A; Belda C; Gonzalez-Barón M
Cancer Chemother Pharmacol; 2006 Oct; 58(4):527-31. PubMed ID: 16555090
[TBL] [Abstract][Full Text] [Related]
25. Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.
Mattson K
Semin Oncol; 1999 Jun; 26(3 Suppl 10):25-8. PubMed ID: 10437748
[TBL] [Abstract][Full Text] [Related]
26. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.
Engels FK; Sparreboom A; Mathot RA; Verweij J
Br J Cancer; 2005 Jul; 93(2):173-7. PubMed ID: 16012521
[TBL] [Abstract][Full Text] [Related]
27. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
Belani CP
Lung Cancer; 2005 Dec; 50S2():S3-S8. PubMed ID: 16551520
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel in the management of advanced non-small cell lung cancer.
Miller VA
Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
[TBL] [Abstract][Full Text] [Related]
29. First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel.
Ramalingam S
Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S77-82. PubMed ID: 16384540
[TBL] [Abstract][Full Text] [Related]
30. The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review.
Hong WK
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):9-15. PubMed ID: 12108903
[TBL] [Abstract][Full Text] [Related]
31. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer.
Tamiya A; Naito T; Miura S; Morii S; Tsuya A; Nakamura Y; Kaira K; Murakami H; Takahashi T; Yamamoto N; Endo M
Anticancer Res; 2012 Mar; 32(3):1103-6. PubMed ID: 22399640
[TBL] [Abstract][Full Text] [Related]
32. Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?
Sumpter K; Harper-Wynne C; Yeoh C; Popat S; Ashley S; Norton A; O'Brien M
Lung Cancer; 2004 Mar; 43(3):369-70. PubMed ID: 15165099
[No Abstract] [Full Text] [Related]
33. The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.
Agata N; Nogi H; Bamberg M; Milhollen M; Pu M; Weitman S; Kharbanda S; Kufe D
Cancer Chemother Pharmacol; 2005 Dec; 56(6):610-4. PubMed ID: 15947930
[TBL] [Abstract][Full Text] [Related]
34. What is the role of novel taxanes in non-small-cell lung cancer?
Spigel DR; Greco FA
Clin Lung Cancer; 2008; 9 Suppl 3():S116-21. PubMed ID: 19419925
[TBL] [Abstract][Full Text] [Related]
35. Taxanes for advanced non-small cell lung cancer.
Ramalingam S; Belani CP
Expert Opin Pharmacother; 2002 Dec; 3(12):1693-709. PubMed ID: 12472367
[TBL] [Abstract][Full Text] [Related]
36. The role of docetaxel in N2 locally advanced non-small-cell lung cancer.
Pillot G; Govindan R
Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S87-92. PubMed ID: 16384542
[TBL] [Abstract][Full Text] [Related]
37. [Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].
Manegold C
Med Klin (Munich); 1998 Sep; 93 Suppl 3():16-21. PubMed ID: 9796220
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel in the management of ovarian cancer.
Blagden SP; Kaye SB
Expert Rev Anticancer Ther; 2005 Apr; 5(2):203-14. PubMed ID: 15877518
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.
Betticher DC; Rosell R
Lung Cancer; 2004 Dec; 46 Suppl 2():S23-32. PubMed ID: 15698528
[TBL] [Abstract][Full Text] [Related]
40. Docetaxel: promising and novel combinations in ovarian cancer.
Mäenpää JU
Br J Cancer; 2003 Dec; 89 Suppl 3(Suppl 3):S29-34. PubMed ID: 14661044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
